Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Evolent Health, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Services-Management Services
Prev close 3.74 · gapped above the open, never looked back. High/low 4.07 at 9:30 am ET, 3.74 at 3:45 pm ET.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of EVH revenue | Skew |
|---|---|---|---|
| MOHMolina Healthcare, Inc. | 1.06% | 25.70% | 24× |
| CNCCentene Corporation | 0.12% | 12.20% | 104× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Molina Healthcare, Inc. 25.7% 13.7% 13.5%”
$482M relationship24× more of EVH’s book than MOH’s
basisEVH fy2025 · closed 2025-12 $1.9BMOH fy2025 · closed 2025-12 $45.4B
FILING10-K0001628908-26-000015cik 0001628908
“Cook County Health and Hospitals System 16.4% 11.5% 15.7%”
$308M relationship
basisEVH fy2025 · closed 2025-12 $1.9B
FILING10-K0001628908-26-000015cik 0001628908
“Florida Blue 14.2% 12.9% 10.4%”
$266M relationship
basisEVH fy2025 · closed 2025-12 $1.9B
FILING10-K0001628908-26-000015cik 0001628908
“Centene Corporation 12.2% * *”
$229M relationship104× more of EVH’s book than CNC’s
basisEVH fy2025 · closed 2025-12 $1.9BCNC fy2025 · closed 2025-12 $195B
FILING10-K0001628908-26-000015cik 0001628908
“In December 2025, we acquired Evolent Health, Inc.'s accountable care business, adding over 120,000 attributed lives through the MSSP, as well as various commercial and Medicare Advantage programs.”
FILING10-K0001759655-26-000010cik 0001759655disclosed by PRVA
“On December 6, 2024 (the "Amendment No. 3 Effective Date"), the Company entered into Amendment No. 3 ("Amendment No. 3") to its credit agreement, by and among the Company, the Borrower, certain subsidiaries of the Company, as co-borrowers and guarantors, the lenders from time to time party thereto, and Ares Capital Corporation ("Ares") (as amended, the "First Lien Credit Agreement") that provided new secured debt financing in the form of (i) additional commitments under the Company's existing asset-based revolving credit facility in an aggregate principal amount equal to $50.0 million (the "2024 Revolver Increase", and together with the initial asset-based revolving credit commitments in an aggregate principal amount of $50.0 million obtained by the Company in 2022 (the "Initial Revolving Facility") and the additional commitments in an aggregate amount equal to $25.0 million obtained by the Company in 2023, the "Revolving Facility"), (ii) a new delayed draw term loan facility in an aggregate principal amount equal to $125.0 million (the "2024-A Delayed Draw Term Loan Facility"), and (iii) a new delayed draw term loan facility in an aggregate principal amount equal to $75.0 million (the "2024-B Delayed Draw Term Loan Facility" and together with the 2024 Revolver Increase and the 2024-A Delayed Draw Term Loan Facility, the "2024 Incremental Facilities"; the initial term loan facility obtained by the Company in 2022 under the First Lien Credit Agreement and the additional term loans entered into by the Company in 2023, the 2024-A Delayed Draw Term Loan Facility and the 2024-B Delayed Draw Term Loan Facility, as amended, are collectively 43 referred to herein as the "Term Loan Facility"; the Revolving Facility and the Term Loan Facility are collectively referred to herein as the "First Lien Credit Facilities").”
FILING10-K0001628908-26-000015cik 0001628908
“Humana Insurance Company * 19.3% 12.0%”
FILING10-K0001628908-26-000015cik 0001628908
“Revenue from Evolent Care Partners 107,848 257,143”
FILING10-K0001628908-26-000015cik 0001628908
Watchlist prices, news filtered to it, and its next report on your desk.
Evolent Health, Inc. has 1 disclosed supplier and 7 disclosed customers. Each one is named in an SEC filing, either Evolent Health, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
EVH (Evolent Health, Inc.) has 1 disclosed suppliers and 7 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: MOH −3.09%, in financials.